French brand Face à Face is continuing its F collection with bolder, more expressive figures – displaying frictions between retro and future. Sun model Flow offers smooth curves with playful accents f
Tattoo-associated uveitis becoming a regular occurrence in Australia
A non-Chinese study of repeated low-level red-light (RLRL) therapy in combination with ortho-k found it effective and safe for myopia control in Caucasian children in Spain, supporting the potential g
Ophthalmic surgical and equipment supplier OphthalmoPro is growing its presence in the New Zealand market with the appointment of a territory manager, David Harris, based in Auckland. Harris, an exper
The FDA has granted investigational device exemption approval to EyeYon Medical to begin a clinical study of EndoArt, the company’s synthetic endothelial implant for chronic corneal oedema. The I
The authors of a University of Auckland study say keratitis after corneal transplantation remains an important threat to graft survival, with infection episodes markedly increasing the likelihood of g
Who's who among the 56th RANZCO Congress graduation and awards ceremony
Interruptions to intravitreal anti-VEGF therapy for neovascular AMD occurred among more than a quarter of patients in an Italian study. The multicentre retrospective analysis, published in the B
Continuous positive airway pressure (CPAP) therapy produces short-term increases in intraocular pressure (IOP) in adults with obstructive sleep apnoea (OSA), according to a Singaporean systematic revi
Authors of an international study identified a distinct genetic signature underpinning reticular pseudodrusen, a high-risk subtype of age-related macular degeneration (AMD), which they said reinforces
Twelve-month real-world data demonstrated that switching from a first-generation VEGF inhibitor to brolucizumab (Beovu) achieved a clinically significant extension of the treatment interval in patient
A farewell to Dr David Squirrell from colleague Olga Brochner
